Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BACE1 | P56817 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16699727 | 1.00 | BACE1 (0.30) | BACE1 | |
| SCHEMBL1535723 | 0.99 | BACE1 (0.31) | BACE1 | |
| SCHEMBL4604431 | 0.88 | — | — | |
| SCHEMBL1942951 | 0.87 | BACE1 (0.32) | BACE1 | |
| SCHEMBL4605446 | 0.87 | — | — | |
| SCHEMBL2384831 | 0.85 | TSHR (0.34) | — | |
| SCHEMBL29649091 | 0.85 | — | — | |
| SCHEMBL1535715 | 0.84 | — | — | |
| SCHEMBL1535718 | 0.83 | — | — | |
| SCHEMBL4650164 | 0.83 | BACE1 (0.31) | BACE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1135 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240018333-A1 | Producing Recycled Carbon Black from Waste Tires | EXXONMOBIL TECHNOLOGY & ENGINEERING COMPANY (US) | 2024-01-18 | — | — | US | claimed |
| EP-3287458-B1 | HYBRID CYCLIC LIBRARIES AND SCREENING THEREOF | UNIV JOHNS HOPKINS (US) | 2022-07-13 | — | — | EP | claimed |
| EP-4013736-A1 | BRANCHED ALKANES AND PROCESS FOR PREPARING SAME | L'OREAL (FR) | 2022-06-22 | — | — | EP | claimed |
| US-20210340285-A1 | METHOD FOR PRODUCING HYDROGENATED NITRILE RUBBER AND HNBR COMPOSITIONS THEREOF | ARLANXEO DEUTSCHLAND GMBH (DE) | 2021-11-04 | — | — | US | claimed |
| US-20200299253-A1 | SUBSTITUTED 1,2,3,4-TETRAHYDRO-1,1'-BIPHENYL COMPOUNDS | UNIVERSITY OF SOUTH FLORIDA | 2020-09-24 | — | — | US | claimed |
| US-10640482-B2 | Synthesis of cannabinoids | UNIVERSITY OF SOUTH FLORIDA (US) | 2020-05-05 | — | — | US | claimed |
| US-20190023680-A1 | SYNTHESIS OF CANNABINOIDS | UNIVERSITY OF SOUTH FLORIDA (US) | 2019-01-24 | — | — | US | claimed |
| US-20180222942-A1 | HYBRID CYCLIC LIBRARIES AND SCREENS THEREOF | THE JOHNS HOPKINS UNIVERSITY | 2018-08-09 | — | — | US | claimed |
| EP-3287458-A2 | HYBRID CYCLIC LIBRARIES AND SCREENS THEREOF | The Johns Hopkins University (US) | 2018-02-28 | — | — | EP | claimed |
| US-20180050329-A1 | Hybrid Catalyst for Olefin Metathesis | SAUDI ARABIAN OIL COMPANY (SA) | 2018-02-22 | — | — | US | claimed |
| WO-2009155517-A2 | OLEFIN FUNCTIONALIZATION BY METATHESIS REACTION | EXXONMOBIL CHEMICAL PATENT INC. (US) | 2009-12-23 | — | — | WO | claimed |
| US-7550607-B2 | Method of preparation of heterocyclic molecules with pharmaceutical, pharmaceutical excipient, cosmeceutical, agrochemical and industrial uses | AUSPEX PHARMACEUTICAL, INC. (US) | 2009-06-23 | — | — | US | claimed |
| US-20080227851-A1 | LAULIMALIDE AND LAULIMALIDE ANALOGS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2008-09-18 | — | — | US | claimed |
| EP-1673328-B1 | AN IMPROVED PROCESS FOR THE SYNTHESIS OF UNSATURATED ALCOHOLS | DOW GLOBAL TECHNOLOGIES INC (US) | 2008-07-09 | — | — | EP | claimed |
| EP-1594835-A4 | METHOD OF PREPARATION OF HETEROCYCLIC MOLECULES WITH PHARMACEUTICAL PHARMACEUTICAL EXCIPIENT COSMECEUTICAL AGROCHEMICAL AND INDUSTRIAL USES | AUSPEX PHARMACEUTICALS INC (US) | 2007-05-02 | — | — | EP | claimed |
| US-7176336-B2 | Preparing 9-octadecene-7,12-diol by catalyzing methyl ricinoleate derived from a seed oil, in presence of a metathesis catalyst; improved yield; use in manufacture of surfactants and thermoplastic polyurethanes | DOW GLOBAL TECHNOLOGIES INC. (US) | 2007-02-13 | — | — | US | claimed |
| US-20060173199-A1 | Method of preparation of heterocyclic molecules with pharmaceutical, pharmaceutical excipient, cosmeceutical, agrochemical and industrial uses | HONG BORCHERNG | 2006-08-03 | — | — | US | claimed |
| EP-1594835-A2 | METHOD OF PREPARATION OF HETEROCYCLIC MOLECULES WITH PHARMACEUTICAL PHARMACEUTICAL EXCIPIENT COSMECEUTICAL AGROCHEMICAL AND INDUSTRIAL USES | Auspex Pharmaceuticals, Inc. (US) | 2005-11-16 | — | — | EP | claimed |
| US-20050080301-A1 | Process for the synthesis of unsaturated alcohols | DOW GLOBAL TECHNOLOGIES LLC | 2005-04-14 | — | — | US | claimed |
| WO-2004064745-A2 | METHOD OF PREPARATION OF HETEROCYCLIC MOLECULES WITH PHARMACEUTICAL PHARMACEUTICAL EXCIPIENT COSMECEUTICAL AGROCHEMICAL AND INDUSTRIAL USES | AUSPEX PHARMACEUTICALS, INC. (US) | 2004-08-05 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080227851-A1 | LAULIMALIDE AND LAULIMALIDE ANALOGS | SSB, LPXN, LTA | BACE1 4341/4885 |
| US-20050080301-A1 | Process for the synthesis of unsaturated alcohols | FASN, SQLE, ALOX12 | BACE1 2880/4885 |
| US-20190023680-A1 | SYNTHESIS OF CANNABINOIDS | CNR1, CNR2, FAAH | BACE1 1647/4885 |
| US-10640482-B2 | Synthesis of cannabinoids | CNR1, CNR2, FAAH | BACE1 1647/4885 |
| US-20200299253-A1 | SUBSTITUTED 1,2,3,4-TETRAHYDRO-1,1'-BIPHENYL COMPOUNDS | CYP1B1, CYP4B1, CYP1A1 | BACE1 532/4885 |
| US-20060173199-A1 | Method of preparation of heterocyclic molecules with pharmaceutical, pharmaceutical excipient, cosmeceutical, agrochemical and industrial uses | LSS, DHPS, CYP51A1 | BACE1 984/4885 |
| US-20180222942-A1 | HYBRID CYCLIC LIBRARIES AND SCREENS THEREOF | CACYBP, HSPBP1, PEBP1 | BACE1 2967/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.